Cipla SWOT Analysis, Competitors & USP

Cipla

Pharmaceuticals

Pharma and Healthcare

Caring for life

Commitment to make medicines affordable and accessible particularly to cancer patients

AIDS, respiratory disease, cancer cardiovascular disease, arthritis

Customers of various flavors and fragrances, OTC products, prescription products, pesticides, agrochemicals, doctors

They use latest technology to concentrate all their knowledge of over seven decades in developing life saving drugs

Below are the Strengths in the SWOT Analysis of Cipla:

1. Cipla has developed good positive image by providing support to cancer patients by issuing drugs at low cost
2. Imminent commencement of the Fixed-Dose combination for treatment of uncomplicated P. falciparum malaria to tackle the 200+ million cases of malaria globally

3. Initiation of ‘No Touch Breast Scan’ a step forward in the screening technology in India.
4. A foremost player in anti-infective and anti-asthmatic formulations.
5. Has a strong employee force of over 16,000

Here are the weaknesses in the Cipla SWOT Analysis:

1. Strong competition from international and domestic giants means limited market share

2. Cipla had faced problems during negative campaign by AHF

Following are the Opportunities in Cipla SWOT Analysis:

1. It can venture into Alzheimer’s disease medication
2. They can use Viramune generic to achieve higher growth.

3. Increased investment in the budding markets, to push expansion in the global economy

The threats in the SWOT Analysis of Cipla are as mentioned:

1. Constant price rises in the Indian country is taking its toll and compounding the problem
2.The Indian Rupee depreciated as compared to the US Dollar

3. Fluctuations in currency exchange rates have a noteworthy impact on the Company’s operations and financial results.

Below are the top 4 competitors of Cipla:

1. Sun Pharmaceuticals
2. Dr. Reddy’s laboratories

3. Lupin

4. Ranbaxy labs